Atrium Biotech USA

Permanently closed
Call
Website

Advertisement

490 Boston Post Rd Ste 2
Sudbury, MA 01776
+1 (800) 753-2277
https://www.pureencapsulations.com

Atrium Biotech USA, home to the Pure Encapsulations brand, has dedicated over 30 years to researching, innovating, and developing a comprehensive line of premium supplements. Their products are formulated with high-quality, pure ingredients that are backed by verifiable science and are free from unnecessary additives and many common allergens.

Committed to excellence, Pure Encapsulations aims to provide healthcare professionals and consumers with supplements that emphasize quality and efficacy. Their focus on pure ingredients underscores their mission to contribute positively to health and wellness.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Real estate managers

Eastern States Medical

Eastern States Medical in Wellesley is located near Wellesley College, a renowned institution known for empowering its students to achieve their highest aspirations and excel in any environment. With a prime location near this prestigious college, Eastern States Medical offers a convenient and accessible healthcare option for the community. Generated from their website's infomation
Sizes, Real estate managers, Services, nec, nec

The Dodge Company

The Dodge Company, headquartered in Billerica, MA, is the world's largest supplier of embalming chemicals, instruments, supplies, and urns, serving the funeral industry for over a century. With a commitment to customer service and innovative solutions, Dodge has expanded its catalog to include nearly every tool and supply needed by morticians and funeral homes. Generated from the website
Real estate managers, Drugs and drug proprietaries

Tari Pharmaceuticals

Constant Therapeutics LLC is a private biopharmaceutical company based in Cambridge, specializing in the development of peptide and small molecule drugs. The company is currently focused on advancing Mas receptor agonists, including their lead drug candidate, TXA127, for the treatment of COVID-19, CNS, and rare disorders. TXA127, a pharmaceutical formulation of the natural human peptide angiotensin-1-7 (Ang-1-7), represents the forefront of Constant Therapeutics' innovative approach to addressing critical medical needs through cutting-edge drug development. With a commitment to clinical excellence, the company aims to make significant advancements in the field of biopharmaceuticals. Generated from their website's infomation
United States›Massachusetts›Sudbury›Atrium Biotech USA

Partial Data by Foursquare.

Advertisement